Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

[The action of neuroleptics on different types of catalepsy in rats with a genetic predisposition to catatonic reactions].

Kolpakov VG, Nikulina EM, Alekhina TA, Gevorgian MM.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1995 Mar-Apr;45(2):388-94. Russian.

PMID:
7597835
2.

Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.

Jelovac N, Sikiric P, Rucman R, Petek M, Marovic A, Perovic D, Seiwerth S, Mise S, Turkovic B, Dodig G, Miklic P, Buljat G, Prkacin I.

Eur J Pharmacol. 1999 Aug 20;379(1):19-31.

PMID:
10499368
3.

[The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].

Skrinskaia IuA, Popova NK, Nikulina EM, Kulikov AV.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1997 Nov-Dec;47(6):1032-9. Russian.

PMID:
9472169
4.

[The predisposition to catatonic reactions, monoamine oxidase and the delta-sleep peptide in rats].

Voĭtenko NN, Kolpakov VG.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1991 Nov-Dec;41(6):1239-44. Russian.

PMID:
1369574
5.

[Selection of Wistar rats for predisposition to catalepsy].

Barykina NN, Chepkasov IL, Alekhina TA, Kolpakov VG.

Genetika. 1983 Dec;19(12):2014-21. Russian.

PMID:
6686570
6.

Anticatatonic effect of venoruton.

Aley KO, Kulkarni SK.

Methods Find Exp Clin Pharmacol. 1988 Apr;10(4):263-5.

PMID:
2898576
7.
8.
9.

Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.

Kleven MS, Barret-Grévoz C, Bruins Slot L, Newman-Tancredi A.

Neuropharmacology. 2005 Aug;49(2):135-43. Epub 2005 Apr 1.

PMID:
15996562
10.

[The role of the genotype in the cataleptogenic effect of neuroleptics].

Skrinskaia IuA, Nikulina EM, Popova NK.

Eksp Klin Farmakol. 1992 Nov-Dec;55(6):7-9. Russian.

PMID:
1363957
11.

The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis.

Worms P, Willigens MT, Continsouza-Blanc D, Lloyd KG.

Eur J Pharmacol. 1985 Jul 11;113(1):53-9.

PMID:
2864264
12.

Anticataleptic effect of taurine: interaction with antiparkinsonian agents.

Zebrowska-Lupina I, Porowska A.

Pol J Pharmacol Pharm. 1987 Jul-Aug;39(4):329-35.

PMID:
2897118
13.
14.

Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.

Brus R, Krzemiński T, Piguła J.

Pol J Pharmacol Pharm. 1983 Sep-Oct;35(5):377-82.

PMID:
6686676
15.

Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.

Herman ZS, Słomińska-Zurek J, Kryk A, Kmieciak-Kołada K.

Pol J Pharmacol Pharm. 1978 Sep-Oct;30(5):639-46.

PMID:
35782
16.

[Thermal interhemispheric asymmetry of the brain in rats in a cataleptic state].

Petrova EV.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1999 Mar-Apr;49(2):338-44. Russian.

PMID:
10486903
17.

The attenuating effect of carteolol hydrochloride, a beta-adrenoceptor antagonist, on neuroleptic-induced catalepsy in rats.

Kikuchi T, Uwahodo Y, Tottori K, Nakai M, Morita S.

Psychopharmacology (Berl). 1997 May;131(2):108-14.

PMID:
9201797
18.

Effect of chronic thyroxine treatment on catalepsy in rats.

Kulikov AV, Barykina NN, Tikhonova MA, Chuguy VF, Kolpakov VG, Popova NK.

Neurosci Lett. 2002 Sep 20;330(2):207-9.

PMID:
12231448
19.

[Dual manifestation of catatonic reaction in rats].

Alekhina TA, Prokudina OI, Chuguĭ VF, Shikhevich SG, Barykina NN, Kolpakov VG.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2005 Jul-Aug;55(4):536-42. Russian.

PMID:
16217968
20.

Effects of thyroid hormone deficiency on behavior in rat strains with different predisposition to catalepsy.

Barykina NN, Chuguy VF, Alekhina TA, Kolpakov VG, Maksiutova AV, Kulikov AV.

Physiol Behav. 2002 Apr 15;75(5):733-7.

PMID:
12020738

Supplemental Content

Support Center